Therapeutic Nanobodies and Intrabodies Rewriting the Rules of Target Engagement David Alvaro, Ph.D. ++++++

https://www.pharmasalmanac.com/articles/therapeutic-nanobodies-and-intrabodies-rewriting-the-rules-of-target-engagement Unlocking the Power of Real-World Data in Long-Term Care Jeff Wessinger https://www.pharmasalmanac.com/articles/unlocking-the-power-of-real-world-data-in-long-term-care Sex Differences, Gender Biases: What Are We Really Studying in Preclinical Research? Serene Lee https://www.pharmasalmanac.com/articles/sex-differences-gender-biases-what-are-we-really-studying-in-preclinical-research Designer Control: DREADDs and the Next Generation of Targeted Neuromodulation David Alvaro, Ph.D. https://www.pharmasalmanac.com/articles/designer-control-dreadds-and-the-next-generation-of-targeted-neuromodulation The Other Data Gap: Reimagining Clinical Research to Include Pregnant and Lactating Women David Alvaro, Ph.D. https://www.pharmasalmanac.com/articles/the-other-data-gap-reimagining-clinical-research-to-include-pregnant-and-lactating-women Leveraging Advanced GMP Release and Stability Testing Methods to Accelerate New Drug Development Gerhard Sax, Dr. rer. nat. Carsten Kroeger, Dr. rer. nat. https://www.pharmasalmanac.com/articles/leveraging-advanced-gmp-release-and-stability-testing-methods-to-accelerate-new-drug-development